PMID- 30759626
OWN - NLM
STAT- MEDLINE
DCOM- 20190320
LR  - 20190320
IS  - 1527-3792 (Electronic)
IS  - 0022-5347 (Linking)
VI  - 201
IP  - 3
DP  - 2019 Mar
TI  - Re: Long-Term Dutasteride Therapy in Men with Benign Prostatic Hyperplasia Alters
      Glucose and Lipid Profiles and Increases Severity of Erectile Dysfunction.
PG  - 416-417
LID - 10.1097/01.JU.0000553653.09278.18 [doi]
FAU - Kaplan, Steven A
AU  - Kaplan SA
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - J Urol
JT  - The Journal of urology
JID - 0376374
RN  - 0 (5-alpha Reductase Inhibitors)
RN  - 0 (Azasteroids)
RN  - 0 (Lipids)
RN  - IY9XDZ35W2 (Glucose)
RN  - O0J6XJN02I (Dutasteride)
SB  - AIM
SB  - IM
CON - Horm Mol Biol Clin Investig. 2017 Jun 21;30(3):null. PMID: 28632494
MH  - 5-alpha Reductase Inhibitors
MH  - Azasteroids
MH  - Dutasteride
MH  - *Erectile Dysfunction
MH  - Glucose
MH  - Humans
MH  - Lipids
MH  - Male
MH  - *Prostatic Hyperplasia
EDAT- 2019/02/15 06:00
MHDA- 2019/03/21 06:00
CRDT- 2019/02/15 06:00
PHST- 2019/02/15 06:00 [entrez]
PHST- 2019/02/15 06:00 [pubmed]
PHST- 2019/03/21 06:00 [medline]
AID - 10.1097/01.JU.0000553653.09278.18 [doi]
AID - 00076734-201903000-00006 [pii]
PST - ppublish
SO  - J Urol. 2019 Mar;201(3):416-417. doi: 10.1097/01.JU.0000553653.09278.18.